Paper422302
Pharmacokinetics of l-carnitine in man following intravenous infusion of dl-carnitine.
Welling PG and 3 others. Int J Clin Pharmacol Biopharm, 1979. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Pharmacokinetics of l-carnitine in man following intravenous infusion of dl-carnitine. Papers, record 422302. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/422302
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carnitine | Major topic |
| Adult | |
| Aged | |
| Humans | |
| Infusions, Parenteral | |
| Kinetics | |
| Male | |
| Middle Aged | |
| Stereoisomerism | |
| Time Factors |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 12948009 | L-carnitine transport in kidney of normotensive, Wistar-Kyoto rats: effect of chronic L-carnitine administration. | Pharm Res | 2003 | https://conductscience.org/library/papers/12948009 | PubMed |
| 12908852 | Pharmacokinetics of L-carnitine. | Clin Pharmacokinet | 2003 | https://conductscience.org/library/papers/12908852 | PubMed |
| 6733367 | Anti-arrhythmic effects of (-)-carnitine chloride and its acetyl analogue on canine late ventricular arrhythmia induced by ligation of the coronary artery as related to improvement of mitochondrial function. | Br J Pharmacol | 1984 | https://conductscience.org/library/papers/6733367 | PubMed |
| 3383994 | Pharmacokinetics and safety of l-carnitine infused i.v. in healthy subjects. | Eur J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3383994 | PubMed |
| 3308409 | l-Carnitine. A preliminary review of its pharmacokinetics, and its therapeutic use in ischaemic cardiac disease and primary and secondary carnitine deficiencies in relationship to its role in fatty acid metabolism. | Drugs | 1987 | https://conductscience.org/library/papers/3308409 | PubMed |
| 3234464 | Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects. | Eur J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3234464 | PubMed |
| 3220097 | Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects. | Eur J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3220097 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/422302
GET https://conductscience.org/api/papers/v1/422302/authors